Myomo names Mary — Katherine McClure chief commercial officer as Micah Mitchell exits

Myomo named Mary-Katherine “Katie” McClure chief commercial officer, effective Oct. 12, 2026. McClure joins from Inspire Medical Systems, where she worked since 2018 amid revenue growth from about $50 million to nearly $1 billion. Earlier roles included senior medical device sales posts at Medtronic, Tobii Dynavox, Johnson & Johnson. Outgoing chief commercial officer Micah Mitchell will depart following a transition period ending Dec. 23, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myomo Inc. published the original content used to generate this news brief via (Ref. ID: 202610121605BIZWIRE_USPR_____20261012_BW506126) on October 12, 2026, and is solely responsible for the information contained therein. (C)